{
  "id": 6273255,
  "title": "BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-T",
  "url": "https://urgent.news/2026/09/08/brainchild-bio-gets-116m-for-pivotal-trial-of-pediatric-brain-tumor",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T11:00:53.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/brainchild-bio-gets-116m-for-trial-of-pediatric-brain-tumor-car-t/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Seattle biotech trying to flip the script on CAR-T cell therapies — making them akin to small molecules for brain tumors — has put together a megaround with the hopes of becoming a commercial-stage company around ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}